BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35220676)

  • 1. Direct Conversion of Human Endothelial Cells Into Liver Cancer-Forming Cells Using Nonintegrative Episomal Vectors.
    Goya T; Horisawa K; Udono M; Ohkawa Y; Ogawa Y; Sekiya S; Suzuki A
    Hepatol Commun; 2022 Jul; 6(7):1725-1740. PubMed ID: 35220676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
    Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
    Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors.
    Cheng Z; He Z; Cai Y; Zhang C; Fu G; Li H; Sun W; Liu C; Cui X; Ning B; Xiang D; Zhou T; Li X; Xie W; Wang H; Ding J
    Cell Res; 2019 Feb; 29(2):124-135. PubMed ID: 30560924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged inhibition of hepatocellular carcinoma cell proliferation by combinatorial expression of defined transcription factors.
    Takashima Y; Horisawa K; Udono M; Ohkawa Y; Suzuki A
    Cancer Sci; 2018 Nov; 109(11):3543-3553. PubMed ID: 30220099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
    Wang F; Hou W; Chitsike L; Xu Y; Bettler C; Perera A; Bank T; Cotler SJ; Dhanarajan A; Denning MF; Ding X; Breslin P; Qiang W; Li J; Koleske AJ; Qiu W
    Gastroenterology; 2020 Jul; 159(1):289-305.e16. PubMed ID: 32171747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
    Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
    Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
    J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
    Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
    Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct reprogramming of human umbilical vein- and peripheral blood-derived endothelial cells into hepatic progenitor cells.
    Inada H; Udono M; Matsuda-Ito K; Horisawa K; Ohkawa Y; Miura S; Goya T; Yamamoto J; Nagasaki M; Ueno K; Saitou D; Suyama M; Maehara Y; Kumamaru W; Ogawa Y; Sekiya S; Suzuki A
    Nat Commun; 2020 Oct; 11(1):5292. PubMed ID: 33087715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.
    Aravalli RN; Talbot NC; Steer CJ
    World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype.
    Chang TM; Hung WC
    Cancer Biol Ther; 2013 Mar; 14(3):222-9. PubMed ID: 23291986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zymolytic grain extract facilitates the conversion of liver tumor cells to hepatocyte-like cells through hepatocyte nuclear factors.
    Hao C; Guo X; Dong Z; Guo Q; Shi W
    Biomed Pharmacother; 2023 Jan; 157():114029. PubMed ID: 36436492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.
    Guo Y; Chen Y; Ito H; Watanabe A; Ge X; Kodama T; Aburatani H
    Gene; 2006 Dec; 384():51-61. PubMed ID: 16971064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of Hepatocellular Cancer Induced Pluripotent Stem Cells Using a Reprogramming Technique.
    Kim HJ; Jeong J; Park S; Jin YW; Lee SS; Lee SB; Choi D
    Gut Liver; 2017 Mar; 11(2):261-269. PubMed ID: 27728962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.
    Dauch D; Rudalska R; Cossa G; Nault JC; Kang TW; Wuestefeld T; Hohmeyer A; Imbeaud S; Yevsa T; Hoenicke L; Pantsar T; Bozko P; Malek NP; Longerich T; Laufer S; Poso A; Zucman-Rossi J; Eilers M; Zender L
    Nat Med; 2016 Jul; 22(7):744-53. PubMed ID: 27213815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells.
    Cheng B; Ling C; Dai Y; Lu Y; Glushakova LG; Gee SW; McGoogan KE; Aslanidi GV; Park M; Stacpoole PW; Siemann D; Liu C; Srivastava A; Ling C
    Gene Ther; 2012 Apr; 19(4):375-84. PubMed ID: 21776025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
    Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K
    Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.